3 High-Risk Biotechs That Could Pop or Drop in 2018 Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three biotech companies that face make-or-break catalysts this year. Source: BioSpace You Might Also Like Halozyme To Host Second Quarter 2017 Financial Results Conference Call July 10, 2017 SoCal's Regulus Sinks After AstraZeneca PLC Bails on Lead NASH Drug June 11, 2017 Charles River Slams Down $800M Cash for Global CRO February 12, 2018
